P-24 Gender differences in overall survival in patients with metastatic pancreatic cancer

Pancreatic cancer is an aggressive disease and bears a dismal prognosis. Data on gender differences in this tumor entity are scare. In single center, real-world retrospective analysis of our registry for pancreatic cancer, we investigated compared the survival data inflammatory parameters male female patients. total, included 42 63 patients with metastatic cancer. Liver metastasis was comparable between genders (69.0% 68.3% patients). Female were older at time initial diagnosis (70.5 versus 69.7 years). Median overall (OS) rates from 13.4 months (95% CI: 7.6-19.1) 7.0 3.2-10.9; p = 0.013), respectively. CRP/albumin ratio significantly lower (p 0.039). (HR 7.7, 0.012) CEA 1.0, 0.821) independent prognostic factors OS. Based analysis, had longer OS than maybe due to activity as reflected by ratio.